Advertisement

Reactions Weekly

, Volume 1581, Issue 1, pp 144–144 | Cite as

Erlotinib/navitoclax

Dehydration, diarrhoea, hypotensive syncope and nausea: 3 case reports
Case report

Reference

  1. Tolcher AW, et al. Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology 76: 1025-1032, No. 5, Nov 2015. Available from: URL: http://doi.org/10.1007/s00280-015-2883-8 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Personalised recommendations